Log In
Print this Print this

ActoBiotic for Clostridium difficile

  Manage Alerts
Collapse Summary General Information
Company Intrexon Corp.
DescriptionActoBiotic delivering toxin-neutralizing antibodies
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationClostridium
Indication DetailsTreat C.difficile asscoiated enteropathy (CDAE)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today